Medicine and Dentistry
Inflammatory Bowel Disease
100%
Patient with Inflammatory Bowel Disease
75%
Metabolome
51%
Trough Level
45%
Personalized Medicine
45%
Cohort Analysis
45%
Metabolite
45%
Infliximab
45%
Microbiome
45%
Gastroscopy
45%
Upper Gastrointestinal Endoscopy
27%
Proteome
21%
Diseases
20%
Chronic Disease
15%
Ulcerative Colitis
15%
Functional Assessment
15%
Crohn's Disease
15%
Liquid Chromatography-Mass Spectrometry
15%
Butyric Acid
15%
Study Participant
15%
Scoring System
15%
Inflammatory Cytokine
15%
Tryptophan
15%
Gut Microbiome
15%
Roseburia
15%
Sarcosine
15%
Methionine
15%
Proline
15%
Faecalibacterium prausnitzii
15%
Metabolomics
15%
Observational Study
15%
Proteomics
15%
Therapeutic Drug Monitoring
13%
Esophagus
9%
Endoscopy
9%
Cross Sectional Study
9%
Reproducibility
9%
Mucus
9%
Duodenum
9%
Metagenome
6%
Gut
6%
Disease Exacerbation
6%
Health Care Cost
6%
Transcriptome
6%
Clinical Management
6%
Nursing and Health Professions
Patient with Inflammatory Bowel Disease
45%
Gastroscopy
45%
Ulcerative Colitis
30%
Functional Assessment
30%
Chronic Disease
30%
Endoscopist
27%
Gastrointestinal Endoscopy
27%
Odds Ratio
15%
Diseases
15%
Inflammatory Bowel Disease
15%
Comorbidity
15%
Crohn's Disease
15%
Sleep Disorder
15%
Confidence Interval
15%
Prevalence
15%
Cross-Sectional Study
9%
Reproducibility
9%
Endoscopy
9%
